HALLE BREISSINGER: Open Payments
NPI 1952055949 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Veloxis Pharmaceuticals, Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Invivyd Inc | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $18 |
| TriSalus Life Sciences, Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Hydrofera LLC | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
Products named: Fabhalta, ENVARSUS, PURIFIED CORTROPHIN GEL, PREVYMIS, PEMGARDA, Rezzayo, TRINAV INFUSION SYSTEM, OCALIVA.
Industry payments across GA — which companies pay providers there.
